PARK VIEW GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P88018 | STOCKPORT, SK5 6ET
Showing results 51-100 of 552
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ferrous fumarate | 1,072 | 62.6K | £2.4K | +47.9% ▲ |
| Glucose blood testing reagents | 1,041 | 87.1K | £12.7K | +31.9% ▲ |
| Prednisolone | 1,032 | 55.2K | £2.3K | +29.2% ▲ |
| Other emollient preparations | 1,031 | 530.3K | £7.0K | +71.6% ▲ |
| Tramadol hydrochloride | 1,007 | 91.2K | £2.6K | +40.5% ▲ |
| Mometasone furoate | 948 | 1,044 | £8.1K | +136.1% ▲ |
| Macrogol 3350 | 934 | 58.1K | £10.0K | -0.4% vs avg |
| Gliclazide | 912 | 67.1K | £2.2K | +7.2% ▲ |
| Finasteride | 885 | 30.0K | £1.1K | +35.1% ▲ |
| Senna | 876 | 38.5K | £924 | +45.6% ▲ |
| Thiamine hydrochloride | 862 | 34.5K | £877 | +63.5% ▲ |
| Estradiol | 824 | 59.8K | £11.0K | +0.4% vs avg |
| Spironolactone | 811 | 21.8K | £2.0K | +50.4% ▲ |
| Sildenafil (Erectile Dysfunction) | 778 | 4,493 | £679 | +54.4% ▲ |
| Indapamide | 771 | 31.3K | £1.2K | -10.6% ▼ |
| Fexofenadine hydrochloride | 766 | 30.8K | £1.3K | -9.9% ▼ |
| Budesonide | 760 | 2,316 | £27.9K | +40.2% ▲ |
| Losartan potassium | 743 | 21.6K | £596 | -58.0% ▼ |
| 742 | 124.5K | £3.7K | +56.4% ▲ | |
| Alendronic acid | 730 | 3,600 | £814 | -2.7% ▼ |
| Rivaroxaban | 720 | 23.4K | £15.4K | +17.7% ▲ |
| Carbocisteine | 719 | 75.6K | £3.3K | +34.7% ▲ |
| Hydrocortisone | 703 | 29.0K | £4.5K | +56.8% ▲ |
| Alogliptin | 687 | 22.0K | £19.8K | +170.9% ▲ |
| Fluticasone propionate (Inhalation) | 671 | 812 | £18.1K | +73.4% ▲ |
| 658 | 7,835 | £2.5K | +163.7% ▲ | |
| Pravastatin sodium | 652 | 21.9K | £1.1K | +100.8% ▲ |
| Diclofenac diethyl | 651 | 84.2K | £6.3K | +83.3% ▲ |
| Doxycycline hyclate | 639 | 8,226 | £808 | +24.7% ▲ |
| Lamotrigine | 624 | 30.0K | £3.5K | +5.7% ▲ |
| Hydroxocobalamin | 618 | 685 | £1.5K | +28.4% ▲ |
| Loratadine | 606 | 27.6K | £629 | +190.0% ▲ |
| Cetirizine hydrochloride | 590 | 37.9K | £1.6K | +18.1% ▲ |
| Semaglutide | 572 | 16.4K | £51.1K | +137.6% ▲ |
| Atenolol | 562 | 19.7K | £449 | -6.8% ▼ |
| Ranolazine | 553 | 28.3K | £5.2K | +225.4% ▲ |
| Morphine sulfate | 549 | 37.2K | £2.0K | -16.3% ▼ |
| Fluticasone/umeclidinium/vilanterol | 540 | 627 | £26.5K | +130.3% ▲ |
| Flucloxacillin sodium | 537 | 22.0K | £1.2K | +19.4% ▲ |
| Mirabegron | 510 | 14.7K | £13.5K | +27.0% ▲ |
| Bendroflumethiazide | 500 | 16.7K | £280 | -35.4% ▼ |
| Desogestrel | 496 | 59.3K | £1.8K | +25.1% ▲ |
| Latanoprost | 480 | 8,073 | £2.7K | -1.1% vs avg |
| 475 | 7,690 | £5.1K | -28.5% ▼ | |
| Zopiclone | 459 | 6,425 | £286 | -17.1% ▼ |
| Promethazine hydrochloride | 457 | 9,668 | £1.1K | +27.9% ▲ |
| Nortriptyline | 452 | 25.9K | £1.1K | +210.7% ▲ |
| Nitrofurantoin | 449 | 5,096 | £2.9K | -5.9% ▼ |
| Edoxaban | 441 | 12.5K | £20.8K | -37.1% ▼ |
| Warfarin sodium | 441 | 28.6K | £957 | -6.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.